tri-specific antibodies (Sanofi/NIAID)

N/A

Report date: 2025/01/26 17:54:16

Base Information

Drug Nametri-specific antibodies (Sanofi/NIAID)
Drug Alias NameVRC-01/PGDM-1400/10E8v4 antibody (SAnofi/NIAID)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT-cell surface antigen CD4 modulators
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A